Բլեոցել 15 ՄՄ Բլեոմիցինի ներարկում (1 սրվակ)

Buy Bleocel 15 IU Bleomycin Injection Online

Բլեոցել 15 ՄՄ Բլեոմիցինի ներարկում (1 սրվակ)

Մի հայացքով

Ընդհանուր անվանում՝ Bleomycin (as bleomycin sulfate)

Բրենդի անվանումը՝ Bleocel

Հզորությունը և փաթեթի չափը՝ 15 IU (15,000 IU) bleomycin per vial; 1 vial

Դեղաչափի ձևը և ընդունման եղանակը. Lyophilised powder for solution for injection/infusion; administered by healthcare professionals (route per protocol)

Թերապևտիկ դաս. Antineoplastic antibiotic (cytotoxic chemotherapy)

Հիմնական ցուցում. Hodgkin lymphoma և testicular germ cell cancer within combination chemotherapy regimens

Մեծահասակների սովորական դեղաչափը. Regimen-based dosing defined by an oncologist; cumulative exposure and monitoring requirements apply

Դեղատոմսի կարգավիճակը՝ Prescription-only / hospital-use medicine

Պահեստավորում՝ Store refrigerated as directed on the pack; protect from light; do not use after expiry

Արտադրանքի նկարագրություն

Bleocel 15 IU Injection contains bleomycin, an antineoplastic antibiotic used in oncology as part of combination chemotherapy regimens. Bleomycin is supplied as a lyophilised powder that must be reconstituted by trained professionals and administered according to protocol in a hospital or specialist treatment setting. Bleocel 15 IU is commonly requested for established regimens in Hodgkin lymphoma և testicular germ cell cancer, where bleomycin may be included based on guideline recommendations, patient factors and specialist judgement.

Each Bleocel pack provides 1 vial containing 15 IU (15,000 IU) of bleomycin, supporting accurate ordering for a prescribed treatment plan. Because cancer regimens are planned in cycles and may require dose modifications, it is important to confirm the required number of vials with the treating oncology team before purchasing. When reviewing bleomycin price or availability online, always compare the same strength and pack size (Bleocel 15 IU, 1 vial) so budgeting and supply planning remain consistent with the clinic’s protocol.

Ջեներիկ դեղերի շուկա պարագաներ Bleocel 15 IU bleomycin injection in original packaging from licensed distribution channels. Product labelling includes strength, batch details and expiry information so hospital pharmacies and oncology teams can verify identity during routine safety checks. Orders are shipped in զգույշ outer packaging to protect privacy, and միջազգային առաքում is available where regulations allow. Our role is limited to access and logistics; all clinical decisions about whether bleomycin is appropriate, how it is combined with other medicines and how side effects are monitored remain with the treating specialists.

Հիմնական կիրառություններ

Bleocel 15 IU bleomycin injection is used primarily within combination chemotherapy regimens for Hodgkin lymphoma և testicular germ cell cancer. Մեջ Hodgkin lymphoma, bleomycin-containing combinations may be selected to treat newly diagnosed disease or selected relapsed settings depending on local protocols, risk profile and treatment goals defined by the oncology team.

In testicular germ cell cancer, bleomycin may be included in specialist regimens aimed at achieving cure or long-term disease control, with careful attention to monitoring and cumulative exposure. The exact place of bleomycin in therapy depends on tumour subtype, stage, overall fitness and other clinical factors, and the final regimen is determined by the treating oncologist in line with local standards of care.

In some settings, bleomycin may also be used for selected other malignancies where bleomycin-containing protocols are locally approved and clinically appropriate. In addition, bleomycin can be used in certain procedural oncology pathways such as chemical pleurodesis for malignant pleural effusion, when performed by specialists in controlled settings. Any such use must follow institutional protocols and local regulations, and it should never be substituted or started without specialist oversight.

How Bleomycin Works in Chemotherapy

Bleomycin works by binding to DNA and generating free-radical mediated damage that leads to single- and double-strand breaks. This disrupts DNA synthesis and repair, resulting in cell-cycle arrest and apoptosis, particularly in rapidly dividing malignant cells. In combination chemotherapy, bleomycin contributes a distinct mechanism that complements other agents targeting different cellular pathways.

A clinically important feature of bleomycin is its tissue-specific toxicity profile. Because pulmonary toxicity is a known risk, oncology teams apply regimen-specific dose limits and monitoring strategies to reduce harm while preserving treatment effectiveness. Patients are monitored for respiratory symptoms and overall tolerance throughout therapy, and treatment plans may be adjusted if the risk of lung injury becomes significant.

Դեղաչափ և կիրառում

Bleocel 15 IU bleomycin injection must be dosed and administered only by trained healthcare professionals. The dose and schedule are regimen-based and depend on the protocol selected by the oncologist, patient characteristics, kidney function and cumulative exposure considerations. Bleomycin is prepared and administered in clinical settings where patients can be observed and supportive care can be provided if needed.

Reconstitution, dilution and handling are managed by hospital pharmacy and nursing staff using cytotoxic safety procedures. Patients should never self-administer bleomycin, attempt to prepare vials at home or self-adjust the schedule. If a dose is delayed or missed, only the treating team can decide how to proceed based on protocol rules, monitoring results and clinical status.

Նախազգուշական միջոցներ

Bleomycin therapy requires careful monitoring because of the risk of pulmonary toxicity. Patients should report new or worsening cough, shortness of breath, chest discomfort or unexplained fever promptly, especially during active treatment. The oncology team may perform baseline and follow-up assessments of lung function depending on the regimen and risk profile, and bleomycin may be reduced or discontinued if lung injury is suspected.

Bleomycin can also cause hypersensitivity reactions, and early doses are administered in settings equipped to manage acute reactions. Kidney function is clinically relevant because reduced clearance can increase exposure and toxicity risk, so renal assessment and ongoing review are important. Patients should provide a complete list of medicines and supplements, as the overall chemotherapy regimen and supportive medicines can influence safety and monitoring needs.

Pregnancy and breastfeeding precautions apply to cytotoxic chemotherapy. Effective contraception is typically recommended during treatment and for a period afterwards as advised by the specialist. Patients should not make independent decisions about pausing or restarting treatment, and any changes to therapy must be guided by the treating oncology team.

Bleomycin Side Effects

Հաճախակի կողմնակի ազդեցություններ

Common side effects may include fever or flu-like symptoms after dosing, fatigue, nausea, reduced appetite and general weakness, often influenced by the full combination regimen. Skin and mucosal reactions can occur, including rash, itching, hyperpigmentation, nail changes or mouth irritation. Some patients experience soreness at the injection site or discomfort related to venous access devices used for infusion. These effects are monitored as part of routine oncology care, and supportive medicines may be used to improve tolerability.

Լուրջ կողմնակի ազդեցություններ

Serious adverse effects require urgent medical attention. New or worsening respiratory symptoms such as persistent cough, shortness of breath or chest tightness can indicate possible lung toxicity and must be assessed promptly. Severe allergic reactions, rapidly worsening fever with signs of infection, or severe skin reactions with blistering or widespread painful rash also require urgent evaluation. Because chemotherapy can affect overall resilience and immune function depending on the regimen, patients should seek immediate care for alarming symptoms and inform clinicians that bleomycin is part of the treatment plan.

Պահեստավորում

Bleocel 15 IU should be stored as stated on the manufacturer label and is commonly kept refrigerated in controlled pharmacy storage to protect stability and maintain traceability. Hospital pharmacies typically manage storage, reconstitution, dilution and cytotoxic waste disposal according to hazardous-drug procedures. Patients are rarely expected to store bleomycin vials at home; if temporary transport or storage is required, it must follow written instructions from the treating facility.

Ինչու՞ գնել Ջեներիկ Մեդս Մարթից

Ջեներիկ դեղերի շուկա helps patients and clinics access essential oncology medicines such as Bleocel 15 IU bleomycin injection through structured sourcing and reliable logistics. We supply Bleocel in original packaging with clear batch and expiry details so pharmacies and oncology teams can verify product identity as part of standard safety workflows. Orders are processed in ԱՄՆ դոլար, supporting treatment planning across cycles without ambiguity about the pack size.

Shipments are packed in զգույշ outer cartons to protect privacy, and միջազգային առաքում with tracking is available where regulations allow. Ջեներիկ դեղերի շուկա does not replace the treating oncologist; decisions about whether bleomycin is appropriate, how it is administered and how side effects are managed must remain with qualified healthcare professionals.

Պատվիրեք հիմա

Պատվիրելուց առաջ Bleocel 15 IU -ից Ջեներիկ դեղերի շուկա, you should have a confirmed diagnosis and a regimen recommendation from your oncology team that includes bleomycin at the appropriate dose and schedule. The clinic will determine how many vials are required based on the number of cycles, patient-specific dosing and potential dose adjustments guided by monitoring results.

Once a plan is in place, select Bleocel 15 IU Injection (1 vial), add it to your cart and complete անվտանգ վճարում մեջ ԱՄՆ դոլար. Your order is shipped in discreet packaging with international delivery where allowed. Do not start, stop or modify bleomycin therapy independently; any questions about dosing, timing or bleomycin side effects must be directed to your treating oncology team.

Հաճախակի տրվող հարցեր about Bleocel (Bleomycin)

Հարց 1: What is Bleocel 15 IU used for?

Bleocel 15 IU պարունակում է bleomycin, which is used mainly as part of combination chemotherapy regimens for Hodgkin lymphoma և testicular germ cell cancer. The decision to include bleomycin depends on local protocols and your oncologist’s assessment of benefits and risks, including pulmonary considerations.

Հարց 2: Is Bleocel taken by mouth or given by injection?

Bleocel is supplied as a vial of lyophilised powder for solution for injection/infusion. It is administered by trained healthcare professionals in clinical settings and is not suitable for self-administration at home.

Հարց 3: How often is bleomycin given?

Bleomycin schedules are regimen-based and vary between protocols. Treatment is usually delivered in cycles with monitoring between doses, and only the treating oncology team can define the exact schedule or make adjustments.

Հարց 4: What side effects should I watch for with bleomycin?

Your team will advise what to expect from the full regimen, but respiratory symptoms such as new cough or shortness of breath should be treated as urgent. Fever, severe rash or any rapidly worsening symptom should also be reported immediately, especially during active chemotherapy.

Հարց 5: Do I need to store Bleocel at home?

Most patients do not store bleomycin at home because preparation and handling are managed by hospital pharmacies under cytotoxic safety procedures. If you are instructed to transport or temporarily store a vial, follow the facility’s written instructions and keep the vial in its original packaging.